Tyrosine Kinase Inhibitors - Epidemiology

Relevant Publications

Cardiovascular disease burden in patients with urological cancers: The new discipline of uro-cardio-oncology.

Issue Release: 2024

Tanreqing injection inhibits stemness and enhances sensitivity of non-small cell lung cancer models to gefitinib through ROS/STAT3 signaling pathway.

Issue Release: 2024

FAK inhibitors in cancer, a patent review - an update on progress.

Issue Release: 2024

A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC.

Issue Release: 2024

Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments.

Issue Release: 2024

Management of Poorly Differentiated Thyroid Cancer and Differentiated High-Grade Thyroid Carcinoma.

Issue Release: 2024

Derivatives of D(-) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis.

Issue Release: 2024

Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.

Issue Release: 2024

Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution.

Issue Release: 2024

The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells.

Issue Release: 2024

Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE.

Issue Release: 2024

Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors.

Issue Release: 2024

The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma.

Issue Release: 2024

New Insights of Target Therapy: Effects of Tyrosine Kinase Inhibitors on Male Gonadal Function: A Systematic Review.

Issue Release: 2024

3D layered co-culture model enhances Trastuzumab Deruxtecan sensitivity and reveals the combined effect with G007-LK in HER2-positive non-small cell lung cancer.

Issue Release: 2024

Targeting FTO suppresses hepatocellular carcinoma by inhibiting ERBB3 and TUBB4A expression.

Issue Release: 2024

Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 3: Theoretical models of drug concentration in blood.

Issue Release: 2024

Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect.

Issue Release: 2024

PKC-α IS INVOLVED IN THE SIGNALING OF PHAGOCYTOSIS INDUCED BY TWO SNAKE VENOM SECRETORY PLAS IN MACROPHAGES.

Issue Release: 2024

Mechanisms of acquired resistance to HER2-Positive breast cancer therapies induced by HER3: A comprehensive review.

Issue Release: 2024

How Do Compromised Healthcare Services Impact Disease Surveillance?

What are the Key Elements in Reporting?

What are Laboratory Tools in Epidemiology?

What are the Challenges of Big Data Analysis in Epidemiology?

How is Osteogenesis Imperfecta Diagnosed?

What are the Side Effects of the DTaP Vaccine?

Why is Sanitation Important?

Why is Understanding Health Burden Important?

Why is STROBE Important?

What is Time Blocking?

Tyrosine Kinase Inhibitors - Epidemiology

Relevant Publications

Partnered Content Networks

Relevant Topics